DBD Stock Analysis: Buy, Sell, or Hold?
DBD - Diebold Nixdorf, Incorporated
$82.30
-0.03 (-0.04%)
▼
5d:
-2.62%
30d:
+9.72%
90d:
+21.03%
BUY
HIGH Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: Apr 30, 2026
TODAY
Smart Money Distribution
DBD is up 6.8% this week, but smart money is buying puts. Top strike: $75 2026-05-15 with 227 OI. Put ratio: 84% View Scanner →
Strength: 6.8/10
Get Alerted When DBD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: DBD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: DBD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$157.25
Based on 13.2% avg growth
INTRINSIC VALUE TODAY
$97.64
15.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DBD is currently trading at $82.30, which is considered fair relative to its 30-day fair value range of $77.00 to $85.74. The stock's valuation (Forward PE: 12.2) is in line with its historical norms (12.7). Remarkably, the market is currently pricing in an annual earnings decline of 1.1% over the next few years. This pessimistic expectation contrasts with the company's recent 815.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, DBD is in a strong uptrend. The price is currently testing key support at $81.67. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $96.67 (+17.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DBD is in a strong uptrend. The price is currently testing key support at $81.67. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $96.67 (+17.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$77.00 -
$85.74
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($96.67)
Trading Range Analysis
30-Day Trading Range
$77.00 -
$85.74
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$4.57
(5.5%)
Support & Resistance Levels
Support Level
$81.67
Resistance Level
$89.05
Current Trend
Strong Uptrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.25
Wall Street Target
$96.67
(+17.5%)
Revenue Growth (YoY)
11.7%
Earnings Growth (YoY)
815.4%
Profit Margin
2.5%
Valuation Discount vs History
-1.1% cheaper
PE vs Historical
12.3 vs 12.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.1%
(market-implied from PE analysis)
1-Year Target
$81.39
(-1%)
2-Year Target
$80.50
(-2%)
3-Year Target
$79.61
(-3%)
3-Yr Target (if PE normalizes)
(PE: 12→13)
$82.52
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: 22.4%)
$253.96
(+209%)
Base:
(SPY PE: 12.3, Growth: 22.4%)
$150.99
(+84%)
Bear:
(PE: 10.4, Growth: 22.4%)
$128.34
(+56%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 32.41 | Current EPS (TTM): $2.54
Bull Case
$181.13
(+120%)
Analyst growth 100.0%, PE expands to 35.7
Base Case
$164.66
(+100%)
Market implied 100.0%, PE stable at 32.4
Bear Case
$55.98
(-32%)
Severe decline -20.0%, PE contracts to 27.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.3 to 12.7
Stabilization Target:
$85.30
(+3.6%)
PE Expansion Potential:
+3.6%
Share & Embed Analysis
Last updated: April 29, 2026 4:14 AM ET
Data refreshes hourly during market hours. Next update: 5:14 AM
Data refreshes hourly during market hours. Next update: 5:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DBD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Millstreet Capital Manag…
SELL
60833 shares
2026-04-16
Millstreet Capital Manag…
SELL
51472 shares
2026-04-15
Millstreet Capital Manag…
SELL
399929 shares
2026-04-08
Top Rated Software - Application Stocks
Top-rated stocks in Software - Application by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
UBER
Uber Technologies Inc |
STRONG BUY
54 analysts |
$103 | 67 BUY |
|
NOW
ServiceNow Inc |
STRONG BUY
47 analysts |
$143 | 55 HOLD |
|
DDOG
Datadog Inc |
STRONG BUY
46 analysts |
$177 | 59 HOLD |
|
GRAB
Grab Holdings Ltd |
STRONG BUY
27 analysts |
$6 | 61 BUY |
|
SHOP
Shopify Inc |
STRONG BUY
50 analysts |
$160 | 63 BUY |
Advanced DBD Option Strategies
Professional options setups generated by AI based on today's DBD price and gamma walls.
